Thrombotic Events and Stroke in the Year After COVID-19 or Other Acute Respiratory Infection
Previous studies have documented an increased risk for thrombotic events 30 days after COVID-19 infection, but less is known about this risk beyond 30 days or compared with risk after other infectious acute respiratory illnesses (ARIs). By using PCORnet data from April 1, 2022-April 30, 2023, we compared the incidences of thrombotic events in the year after COVID-19 illness with other ARI diagnoses in hospitalized and nonhospitalized patients. Overall, the risk for any thrombotic event was higher among patients with COVID-19 compared with patients with other ARIs (incidence ratio 1.63; p<0.05). Nonhospitalized patients with COVID-19 had a 73% increased risk for a thrombotic event in the year after acute illness compared with nonhospitalized patients with ARI (p<0.05). The increased risk for thrombotic events in the year after COVID-19 emphasizes the need for stroke awareness for patients and healthcare professionals.
Authors
- Elizabeth A. Lundeen (ORCID: https://orcid.org/0000-0002-4249-8455)
- Fátima Coronado (ORCID: https://orcid.org/0000-0002-6582-8891)
- Lindsay G. Cowell (ORCID: https://orcid.org/0000-0003-1617-8244)
- Abraham Agedew
- Caroline Pratt
- Emily H. Koumans
- PCORnet Network Partners
- Sharon Saydah
- Jonathan D. Arnold
- Rebecca C. Woodruff
- Jason P. Block
- Alexandra F. Dalton
- Mark Weiner
Publication Details
- Journal
- Emerging infectious diseases
- Published
- 2025-12-01
- DOI
- https://doi.org/10.3201/eid3114.250630
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00